SRPT logo

Sarepta Therapeutics (SRPT) Short Term Debt

SRPT Annual Short Term Debt

$123.33 M
+$107.84 M+696.23%

31 December 2023

SRPT Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SRPT Quarterly Short Term Debt

$91.59 M
+$90.00 K+0.10%

30 September 2024

SRPT Quarterly Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SRPT Short Term Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+696.2%-25.7%
3 y3 years--
5 y5 years--

SRPT Short Term Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+719.4%-25.7%+508.6%
5 y5-yearat high+719.4%-25.7%+508.6%
alltimeall timeat high>+9999.0%-25.7%>+9999.0%

Sarepta Therapeutics Short Term Debt History

DateAnnualQuarterly
Sept 2024
-
$91.59 M(+0.1%)
June 2024
-
$91.50 M(-13.3%)
Mar 2024
-
$105.59 M(-14.4%)
Dec 2023
$123.33 M(+696.2%)
$123.33 M(+696.2%)
Dec 2022
$15.49 M(+2.9%)
$15.49 M(+2.9%)
Dec 2021
$15.05 M(+143.7%)
$15.05 M(+58.2%)
June 2018
-
$9.51 M(+176.1%)
Mar 2018
-
$3.45 M(-44.2%)
Dec 2017
$6.17 M(-38.9%)
$6.17 M(+30.5%)
Sept 2017
-
$4.73 M(-57.8%)
June 2017
-
$11.22 M(-1.1%)
Mar 2017
-
$11.35 M(+12.2%)
Dec 2016
$10.11 M(+19.9%)
$10.11 M(+0.0%)
Sept 2016
-
$10.11 M(+0.0%)
June 2016
-
$10.11 M(+32.9%)
Mar 2016
-
$7.60 M(-9.8%)
Dec 2015
$8.43 M(+225.4%)
$8.43 M(+43.1%)
Sept 2015
-
$5.89 M(+17.6%)
June 2015
-
$5.01 M(+1.6%)
Mar 2015
-
$4.93 M(+90.3%)
Dec 2014
$2.59 M(+2715.2%)
$2.59 M(+3.1%)
Sept 2014
-
$2.51 M(+2516.7%)
June 2014
-
$96.00 K(+2.1%)
Mar 2014
-
$94.00 K(+2.2%)
Dec 2013
$92.00 K
$92.00 K(+1.1%)
DateAnnualQuarterly
Sept 2013
-
$91.00 K(+1.1%)
June 2013
-
$90.00 K(0.0%)
Mar 2013
-
$90.00 K(+1.1%)
Dec 2012
$89.00 K(+4.7%)
$89.00 K(+1.1%)
Sept 2012
-
$88.00 K(+1.1%)
June 2012
-
$87.00 K(+1.2%)
Mar 2012
-
$86.00 K(+1.2%)
Dec 2011
$85.00 K(+4.9%)
$85.00 K(+1.2%)
Sept 2011
-
$84.00 K(+1.2%)
June 2011
-
$83.00 K(+1.2%)
Mar 2011
-
$82.00 K(+1.2%)
Dec 2010
$81.00 K(+5.2%)
$81.00 K(+1.3%)
Sept 2010
-
$80.00 K(+1.3%)
June 2010
-
$79.00 K(+1.3%)
Mar 2010
-
$78.00 K(+1.3%)
Dec 2009
$77.00 K(+4.1%)
$77.00 K(+1.3%)
Sept 2009
-
$76.00 K(0.0%)
June 2009
-
$76.00 K(+1.3%)
Mar 2009
-
$75.00 K(+1.4%)
Dec 2008
$74.00 K(+4.1%)
$74.00 K(+0.4%)
Sept 2008
-
$73.70 K(+1.2%)
June 2008
-
$72.80 K(+180.0%)
Mar 2008
-
$26.00 K(-63.4%)
Dec 2007
$71.10 K
$71.10 K(+1.1%)
Sept 2007
-
$70.30 K(+1.3%)
June 2007
-
$69.40 K

FAQ

  • What is Sarepta Therapeutics annual short term debt?
  • What is the all time high annual short term debt for Sarepta Therapeutics?
  • What is Sarepta Therapeutics annual short term debt year-on-year change?
  • What is Sarepta Therapeutics quarterly short term debt?
  • What is the all time high quarterly short term debt for Sarepta Therapeutics?
  • What is Sarepta Therapeutics quarterly short term debt year-on-year change?

What is Sarepta Therapeutics annual short term debt?

The current annual short term debt of SRPT is $123.33 M

What is the all time high annual short term debt for Sarepta Therapeutics?

Sarepta Therapeutics all-time high annual short term debt is $123.33 M

What is Sarepta Therapeutics annual short term debt year-on-year change?

Over the past year, SRPT annual short term debt has changed by +$107.84 M (+696.23%)

What is Sarepta Therapeutics quarterly short term debt?

The current quarterly short term debt of SRPT is $91.59 M

What is the all time high quarterly short term debt for Sarepta Therapeutics?

Sarepta Therapeutics all-time high quarterly short term debt is $123.33 M

What is Sarepta Therapeutics quarterly short term debt year-on-year change?

Over the past year, SRPT quarterly short term debt has changed by -$31.73 M (-25.73%)